Physician profile
Thomas Metkus
NPI 1417140096
$7,237.05
in general payments reported to CMS, 2019-2025
8 companies · $6,841 in 2025
The $6,841 reported for 2025 was more than what 93% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $16.84 · 2022: $66.37 · 2023: $240 · 2024: $72.80 · 2025: $6,841.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,308 · Consulting Fee: $3,000 · Food and Beverage: $846.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,308.06 |
| Consulting Fee | $3,000.00 |
| Food and Beverage | $845.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $6,576.16 | 2025 | |
| Abiomed | $264.37 | 2023-2025 | Impella |
| Getinge USA Sales, LLC | $194.27 | 2023 | Cardiohelp |
| Angiodynamics, INC. | $58.39 | 2024-2025 | Alphavac |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $57.70 | 2022-2023 | Lifevest |
| Janssen Pharmaceuticals, INC | $34.57 | 2021-2022 | |
| Pfizer INC. | $31.80 | 2024 | |
| Philips North America LLC | $19.79 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Metkus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.